Clinical Trial Update: Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for phosphodiesterase inhibitors in glaucoma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Snippet

Sponsor: Imperial College London | Conditions: Glaucoma | Phase 3 | Status: SUSPENDED